2
Clinical Trials associated with BI 3804379A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Subcutaneous Doses of BI 3804379 in Healthy Male and Female Subjects
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PKs) of BI 3804379 in healthy male and female subjects following administration of single rising doses and administration of multiple rising doses.
100 Clinical Results associated with BI 3804379
100 Translational Medicine associated with BI 3804379
100 Patents (Medical) associated with BI 3804379
100 Deals associated with BI 3804379